In vitro digestion and human gut microbiota fermentation of Bletilla striata polysaccharides and oligosaccharides
Frontiers in Cellular and Infection Microbiology · 01.02.2023 · 13
DOI: 10.3389/fcimb.2023.1105335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 01.02.2023. Verfasst von Qiqi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Department of Education, National Natural Science Foundation of China, Key Research and Development Program of Ningxia.
Abstract (Originalsprache)
Background
Bletilla striata is one of the commonly used traditional Chinese medicine. B. striata polysaccharides (BP) and oligosaccharides (BO) are one of the main components of B. striata , which have been proved to have a variety of biological activities. However, the digestion and fermentation characteristics of BP and BO are still unclear.
Methods
The study evaluated different prebiotic effects of BP and BO by in vitro simulating digestion and gut microbiota fermentation.
Results
The results show that the simulating saliva partly degraded BP, but had no effect on BO. The molecular weights of BP and BO remained basically unchanged in gastric and intestinal digestion. In addition, BP and BO could be rapidly degraded and utilized by gut microbiota. During in vitro fermentation, the growth rates of the BP and BO groups were higher than that of the Control group and the pH value and total carbohydrate content in BP group and BO group decreased significantly. Although the reducing sugar level in the BO group decreased rapidly, it remained at a low level in the BP group. Both BP and BO improved the composition and structure of gut microbiota, indicative of the upregulated abundances of Streptococcus and Veillonella , and the downregulated populations of Escherichia and Bacteroides. There were differences in the SCFA production by gut microbiota and antioxidant activities between the BP and BO groups. The fermentation broth of the BP group displayed a stronger suppression of O 2 -, but a higher scavenging effect on DPPH for the BO group.
Conclusions
BP and BO displayed different digestion and fermentation characteristics in vitro due to their distinct polymerization degrees. The study point towards the potential of BP and BO as prebiotics in the application to human diseases by selectively regulating gut microbiota in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China.
Förderung
- Hubei Provincial Department of Education
- National Natural Science Foundation of China
- Key Research and Development Program of Ningxia
- Major Science and Technology Projects in Yunnan Province
Zitieren
APA
Wang, Q., Chen, H., Yin, M., Cheng, X., Xia, H., Hu, H., Zheng, J., Zhang, Z., & Liu, H. (2023). In vitro digestion and human gut microbiota fermentation of Bletilla striata polysaccharides and oligosaccharides. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1105335
Vancouver
Wang Q, Chen H, Yin M, Cheng X, Xia H, Hu H, et al. In vitro digestion and human gut microbiota fermentation of Bletilla striata polysaccharides and oligosaccharides. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1105335
BibTeX
@article{Wang2023,
author = {Wang, Qiqi and Chen, Huimin and Yin, Mingzhu and Cheng, Xue and Xia, Hui and Hu, Haiming and Zheng, Junping and Zhang, Zhigang and Liu, Hongtao},
title = {In vitro digestion and human gut microbiota fermentation of Bletilla striata polysaccharides and oligosaccharides},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1105335}
}
EUVIMED